Half-Matched stem cell transplant offers new hope for rare blood diseases

NCT ID NCT03520647

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times

Summary

This study tests a stem cell transplant using blood stem cells from a half-matched family donor (like a parent or sibling) for people with severe aplastic anemia, a related bone marrow disorder, or a rare blood disease called PNH. Participants receive chemotherapy and a one-time radiation treatment before the transplant to prepare their body. The goal is to see if this approach helps people live longer without developing chronic graft-versus-host disease, a common complication where donor cells attack the body. The study involves 56 recipients aged 4 to 60 and their donors aged 4 to 75.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA, PNH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.